Digital Therapeutics (DTx) Market worth $17.7 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, Oct. 24, 2022 /PRNewswire/ -- Digital Therapeutics (DTx) Market is projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6% according to a new report

Related Keywords

United States ,India ,Northbrook ,Illinois ,Chicago ,America ,Kostenloser Wertpapierhandel ,Aashish Mehra ,Behavr Inc ,Healthcare Consulting Services Global ,Kaia Health Germany ,Research Reports Consulting ,Health Inc ,Morrow Inc ,Omada Health Inc ,Virta Health Corp ,Pear Therapeutics Inc ,Behavioural Health Software Global ,Welldoc Inc ,Click Therapeutics Inc ,Cognifit Inc ,Noom Inc ,Teladoc Health Inc ,Cognoa Inc ,Better Therapeutics Inc ,Propeller Health ,Akili Inc ,Twill Inc ,Research Insight ,Mindable Health Gmbh Germany ,Canary Health ,Care Management Solutions Global ,Sample Pages ,North America ,Teladoc Health ,Omada Health ,Pear Therapeutics ,Click Therapeutics ,Wellthy Therapeutics ,Better Therapeutics ,Kaia Health ,Mindable Health Gmbh ,Hinge Health ,Free Customization ,Adjacent Market ,Research Reports ,Cloud Computing ,Health Software ,Management Solutions ,Consulting Services ,Engagement Model ,Digital ,Herapeutics ,Market ,North ,Billion ,027 ,Exclusive ,Report ,Marketsandmarkets ,